Displaying 145 - 156 of 452
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Viral Hepatitis
6

AbbVie: Don’t Delay, Let Test and Treat Lead the HCV Elimination Way! - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Displaying 145 - 156 of 452